ID   GALT1_RAT               Reviewed;         559 AA.
AC   Q10473;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   03-AUG-2022, entry version 159.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 1 {ECO:0000305};
DE            EC=2.4.1.41 {ECO:0000269|PubMed:12199709, ECO:0000269|PubMed:12364335, ECO:0000269|PubMed:12419318};
DE   AltName: Full=Polypeptide GalNAc transferase 1;
DE            Short=GalNAc-T1;
DE            Short=pp-GaNTase 1;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 1;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1;
DE   Contains:
DE     RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 1 soluble form;
GN   Name=Galnt1 {ECO:0000312|RGD:620358};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Sublingual gland;
RX   PubMed=8748168; DOI=10.1007/bf00731252;
RA   Hagen F., Gregorie C.A., Tabak L.A.;
RT   "Cloning and sequence homology of a rat UDP-GalNAc:polypeptide N-
RT   acetylgalactosaminyltransferase.";
RL   Glycoconj. J. 12:901-909(1995).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY, AND
RP   MUTAGENESIS OF CYS-106; CYS-212; CYS-214; CYS-235; CYS-330; CYS-339 AND
RP   CYS-408.
RX   PubMed=12199709; DOI=10.1046/j.1432-1033.2002.03123.x;
RA   Tenno M., Toba S., Kezdy F.J., Elhammer A.P., Kurosaka A.;
RT   "Identification of two cysteine residues involved in the binding of UDP-
RT   GalNAc to UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1
RT   (GalNAc-T1).";
RL   Eur. J. Biochem. 269:4308-4316(2002).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY, AND
RP   MUTAGENESIS OF CYS-442; ASP-444; GLY-455; PHE-457; CYS-459; ASN-465;
RP   GLN-466; PHE-468; CYS-482; ASP-484; CYS-497; CYS-523; ASP-525 AND CYS-540.
RX   PubMed=12364335; DOI=10.1074/jbc.m207369200;
RA   Tenno M., Saeki A., Kezdy F.J., Elhammer A.P., Kurosaka A.;
RT   "The lectin domain of UDP-GalNAc:polypeptide N-
RT   acetylgalactosaminyltransferase 1 is involved in O-glycosylation of a
RT   polypeptide with multiple acceptor sites.";
RL   J. Biol. Chem. 277:47088-47096(2002).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY, AND
RP   MUTAGENESIS OF ASP-444; ASP-484 AND ASP-525.
RX   PubMed=12419318; DOI=10.1016/s0006-291x(02)02549-4;
RA   Tenno M., Kezdy F.J., Elhammer A.P., Kurosaka A.;
RT   "Function of the lectin domain of polypeptide N-
RT   acetylgalactosaminyltransferase 1.";
RL   Biochem. Biophys. Res. Commun. 298:755-759(2002).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide
CC       biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a
CC       serine or threonine residue on the protein receptor (PubMed:12199709,
CC       PubMed:12364335, PubMed:12419318). Has a broad spectrum of substrates
CC       such as apomucin-, MUC5AC-, MUC1- and MUC2-derived peptides (By
CC       similarity). {ECO:0000250|UniProtKB:Q10472,
CC       ECO:0000269|PubMed:12199709, ECO:0000269|PubMed:12364335,
CC       ECO:0000269|PubMed:12419318}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-O-
CC         [N-acetyl-alpha-D-galactosaminyl]-L-seryl-[protein] + H(+) + UDP;
CC         Xref=Rhea:RHEA:23956, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12788,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:53604,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:67138; EC=2.4.1.41;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-
CC         O-[N-acetyl-alpha-D-galactosaminyl]-L-threonyl-[protein] + H(+) +
CC         UDP; Xref=Rhea:RHEA:52424, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11689, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:67138, ChEBI:CHEBI:87075; EC=2.4.1.41;
CC         Evidence={ECO:0000269|PubMed:12199709, ECO:0000269|PubMed:12364335,
CC         ECO:0000269|PubMed:12419318};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52425;
CC         Evidence={ECO:0000305|PubMed:12364335, ECO:0000305|PubMed:12419318};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:O08912};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5.1 uM for UDP-N-acetyl-alpha-D-galactosamine
CC         {ECO:0000269|PubMed:12199709, ECO:0000269|PubMed:12364335,
CC         ECO:0000269|PubMed:12419318};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:12199709, ECO:0000269|PubMed:12364335,
CC       ECO:0000269|PubMed:12419318}.
CC   -!- SUBCELLULAR LOCATION: [Polypeptide N-acetylgalactosaminyltransferase
CC       1]: Golgi apparatus, Golgi stack membrane {ECO:0000250}; Single-pass
CC       type II membrane protein {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Polypeptide N-acetylgalactosaminyltransferase 1
CC       soluble form]: Secreted {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Heart, brain, spleen, liver, skeletal muscle and
CC       kidney.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif), which
CC       is probably involved in manganese coordination and substrate binding
CC       and the C-terminal domain (domain B, also called Gal/GalNAc-T motif),
CC       which is probably involved in catalytic reaction and UDP-Gal binding.
CC   -!- DOMAIN: The ricin B-type lectin domain directs the glycopeptide
CC       specificity. It is required in the glycopeptide specificity of enzyme
CC       activity but not for activity with naked peptide substrates, suggesting
CC       that it triggers the catalytic domain to act on GalNAc-glycopeptide
CC       substrates.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U35890; AAC52511.1; -; mRNA.
DR   RefSeq; NP_077349.1; NM_024373.1.
DR   RefSeq; XP_006254533.1; XM_006254471.3.
DR   AlphaFoldDB; Q10473; -.
DR   SMR; Q10473; -.
DR   STRING; 10116.ENSRNOP00000022117; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   GlyGen; Q10473; 2 sites.
DR   PaxDb; Q10473; -.
DR   PRIDE; Q10473; -.
DR   Ensembl; ENSRNOT00000022117; ENSRNOP00000022117; ENSRNOG00000016207.
DR   GeneID; 79214; -.
DR   KEGG; rno:79214; -.
DR   UCSC; RGD:620358; rat.
DR   CTD; 2589; -.
DR   RGD; 620358; Galnt1.
DR   eggNOG; KOG3736; Eukaryota.
DR   GeneTree; ENSGT00940000154732; -.
DR   HOGENOM; CLU_013477_0_1_1; -.
DR   InParanoid; Q10473; -.
DR   OMA; VAEVWMC; -.
DR   OrthoDB; 606683at2759; -.
DR   PhylomeDB; Q10473; -.
DR   TreeFam; TF313267; -.
DR   BRENDA; 2.4.1.41; 5301.
DR   Reactome; R-RNO-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   Reactome; R-RNO-913709; O-linked glycosylation of mucins.
DR   UniPathway; UPA00378; -.
DR   PRO; PR:Q10473; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   Bgee; ENSRNOG00000016207; Expressed in jejunum and 19 other tissues.
DR   Genevisible; Q10473; RN.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; ISS:UniProtKB.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0006493; P:protein O-linked glycosylation; ISS:UniProtKB.
DR   GO; GO:0018242; P:protein O-linked glycosylation via serine; ISO:RGD.
DR   GO; GO:0018243; P:protein O-linked glycosylation via threonine; ISO:RGD.
DR   CDD; cd02510; pp-GalNAc-T; 1.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR045885; GalNAc-T.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; Glycoprotein; Glycosyltransferase; Golgi apparatus; Lectin;
KW   Manganese; Membrane; Metal-binding; Reference proteome; Secreted;
KW   Signal-anchor; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..559
FT                   /note="Polypeptide N-acetylgalactosaminyltransferase 1"
FT                   /id="PRO_0000223390"
FT   CHAIN           41..559
FT                   /note="Polypeptide N-acetylgalactosaminyltransferase 1
FT                   soluble form"
FT                   /id="PRO_0000012263"
FT   TOPO_DOM        1..8
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        9..28
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        29..559
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          429..551
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REGION          115..225
FT                   /note="Catalytic subdomain A"
FT   REGION          285..347
FT                   /note="Catalytic subdomain B"
FT   BINDING         156
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         186
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         209
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         211
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         316
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         344
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         347
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         352
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        95
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        552
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        106..339
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        330..408
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        442..459
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        482..497
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        523..540
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   MUTAGEN         106
FT                   /note="C->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:12199709"
FT   MUTAGEN         212
FT                   /note="C->A: Loss of enzyme activity due to absence of
FT                   interaction between UDP moiety and UDP-GalNAC."
FT                   /evidence="ECO:0000269|PubMed:12199709"
FT   MUTAGEN         214
FT                   /note="C->A: Loss of enzyme activity due to absence of
FT                   interaction between UDP moiety and UDP-GalNAC."
FT                   /evidence="ECO:0000269|PubMed:12199709"
FT   MUTAGEN         235
FT                   /note="C->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:12199709"
FT   MUTAGEN         330
FT                   /note="C->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:12199709"
FT   MUTAGEN         339
FT                   /note="C->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:12199709"
FT   MUTAGEN         408
FT                   /note="C->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:12199709"
FT   MUTAGEN         442
FT                   /note="C->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:12364335"
FT   MUTAGEN         444
FT                   /note="D->A: Induces a strong decrease in activity; loss of
FT                   function; when associated with A-484 and A-525."
FT                   /evidence="ECO:0000269|PubMed:12364335,
FT                   ECO:0000269|PubMed:12419318"
FT   MUTAGEN         455
FT                   /note="G->Q: Induces a decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:12364335"
FT   MUTAGEN         457
FT                   /note="F->A: Little or no effect."
FT                   /evidence="ECO:0000269|PubMed:12364335"
FT   MUTAGEN         459
FT                   /note="C->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:12364335"
FT   MUTAGEN         465
FT                   /note="N->A: Little or no effect."
FT                   /evidence="ECO:0000269|PubMed:12364335"
FT   MUTAGEN         466
FT                   /note="Q->A: Induces a decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:12364335"
FT   MUTAGEN         468
FT                   /note="F->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:12364335"
FT   MUTAGEN         468
FT                   /note="F->W,Y: Little or no effect."
FT                   /evidence="ECO:0000269|PubMed:12364335"
FT   MUTAGEN         482
FT                   /note="C->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:12364335"
FT   MUTAGEN         484
FT                   /note="D->A: Loss of enzyme activity; when associated with
FT                   A-444 and A-525."
FT                   /evidence="ECO:0000269|PubMed:12364335,
FT                   ECO:0000269|PubMed:12419318"
FT   MUTAGEN         497
FT                   /note="C->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:12364335"
FT   MUTAGEN         523
FT                   /note="C->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:12364335"
FT   MUTAGEN         525
FT                   /note="D->A: Loss of enzyme activity; when associated with
FT                   A-444 and A-484."
FT                   /evidence="ECO:0000269|PubMed:12364335,
FT                   ECO:0000269|PubMed:12419318"
FT   MUTAGEN         540
FT                   /note="C->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:12364335"
SQ   SEQUENCE   559 AA;  64229 MW;  5E36A95D9422C853 CRC64;
     MRKFAYCKVV LATSLVWVLL DMFLLLYFSE CNKCEEKKER GLPAGDVLEL VQKPHEGPGE
     MGKPVVIPKE DQEKMKEMFK INQFNLMASE MIAFNRSLPD VRLEGCKTKV YPDSLPTTSV
     VIVFHNEAWS TLLRTVHSVI NRSPRHMIEE IVLVDDASER DFLKRPLESY VKKLKVPVHV
     IRMEQRSGLI RARLKGAAVS KGQVITFLDA HCECTVGWLE PLLARIKHDR RTVVCPIIDV
     ISDDTFEYMA GSDMTYGGFN WKLNFRWYPV PQREMDRRKG DRTLPVRTPT MAGGLFSIDR
     DYFQEIGTYD AGMDIWGGEN LEISFRIWQC GGTLEIVTCS HVGHVFRKAT PYTFPGGTGQ
     IINKNNRRLA EVWMDEFKNF FYIISPGVTK VDYGDISSRV GLRHKLQCKP FSWYLENIYP
     DSQIPRHYFS LGEIRNVETN QCLDNMARKE NEKVGIFNCH GMGGNQVFSY TANKEIRTDD
     LCLDVSKLNG PVTMLKCHHL KGNQLWEYDP VKLTLQHVNS NQCLDKATEE DSQVPSIRDC
     TGSRSQQWLL RNVTLPEIF
//
